Healthcare & Medicine specializing in Cancer Research
Cancer Research · Immunology · Biopharmaceutical Innovation · Translational Oncology
Specialties
Cancer ResearchImmunologyBiopharmaceutical InnovationTranslational Oncology
Professional Services
mRNA Vaccine DevelopmentCancer ImmunotherapyTranslational ResearchBiopharmaceutical ConsultingClinical Trials ManagementPatent Strategy Development
Professional Timeline
Co-founder of BioNTech
Uğur Şahin co-founded BioNTech, which developed the first mRNA-based COVID-19 vaccine.
BioNTech
Chairman of Helmholtz Institute for Translational Oncology
He serves as chairman of the scientific management board at HI-TRON, advancing biopharmaceutical research.
Helmholtz Institute
Inventor of Over 500 Patents
Uğur Şahin is a co-inventor of more than 500 filed patent applications and patents in medical research.
Various
Client Reviews
No reviews yet. Be the first to leave one below.
Leave a Review